HomeNewsTrendsFeaturesGlenmark's R&D gamble
Trending Topics
Elon Musk
Kristin Cabot
David Baszucki
New Zealand Protests
Deepinder Goyal

Glenmark's R&D gamble

With Indian pharma companies willing to cash out, is Glenn Saldanha India’s best bet for a home-grown drug?

September 22, 2011 / 15:14 IST
Story continues below Advertisement
Remove Ad

By: Seema Singh/Forbes India


With Indian pharma companies willing to cash out, is Glenn Saldanha India
first published: Sep 22, 2011 12:35 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today Gold Price Asim Munir Hindustan Zinc Share Price Air India Mumbai Flight India New Zealand Trade Deal Muhammad Motaleb Sikdar Budget 2026 Maharashtra local body elections Goa Election Results
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.